| Metformin in Patients With Fragile X (NCT04141163) | Rowan University | 2019-10-29 |
| A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease (NCT03707730) | Igy Inc. | 2019-10-29 |
| Feasibility of Additional Physiotherapy for Patients Aged 75 and Older (NCT04144634) | Cambridge University Hospitals NHS Foundation Trust | 2019-10-29 |
| Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO) (NCT04170465) | Damanhour University | 2019-10-29 |
| Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer (NCT04175470) | Vejle Hospital | 2019-10-29 |
| TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis (NCT03910738) | University Hospital, Strasbourg, France | 2019-10-29 |
| Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206) (NCT03865082) | Idera Pharmaceuticals, Inc. | 2019-10-29 |
| Imaging the Effects of Bihemispheric Transcranial Stimulation and Motor Training After Stroke. (NCT04195412) | D'Or Institute for Research and Education | 2019-10-29 |
| A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough (NCT04030026) | Trevi Therapeutics | 2019-10-29 |
| Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer (NCT03981614) | Academic and Community Cancer Research United | 2019-10-29 |
| Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial (NCT05468892) | University of Campania Luigi Vanvitelli | 2019-10-29 |
| Safinamide for Multiple System Atrophy (MSA) (NCT03753763) | Zambon SpA | 2019-10-29 |
| Fenfluramine in CDKL5 Deficiency Disorder (CDD) (NCT03861871) | NYU Langone Health | 2019-10-29 |
| A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity (NCT04143945) | Novo Nordisk A/S | 2019-10-28 |
| RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI (NCT03869437) | The University of Queensland | 2019-10-28 |
| APG-115 in Salivary Gland Cancer Trial (NCT03781986) | University of Michigan Rogel Cancer Center | 2019-10-28 |
| Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of Clesrovimab (MK-1654) in Healthy Participants (MK-1654-005) (NCT04086472) | Merck Sharp & Dohme LLC | 2019-10-28 |
| Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia (NCT04054024) | Danish Headache Center | 2019-10-28 |
| Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer (NCT04089189) | Impact Therapeutics, Inc. | 2019-10-28 |
| Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer (NCT04068974) | Peking Union Medical College Hospital | 2019-10-28 |
| Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation (NCT03856216) | M.D. Anderson Cancer Center | 2019-10-28 |
| A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma (NCT03947255) | Seagen Inc. | 2019-10-28 |
| Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer (NCT04304209) | Sun Yat-sen University | 2019-10-28 |
| A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 (NCT03847909) | Novo Nordisk A/S | 2019-10-28 |
| Pramipexole and Morphine for Renal Colic (NCT04160520) | East Carolina University | 2019-10-28 |
| Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS) (NCT04163978) | Sanotize Research and Development corp. | 2019-10-27 |
| Myopia Control With Novel Eye Drops (NCT04301323) | Hai Yen Eye Care | 2019-10-26 |
| The Role and Intervention of TGF-β in Abdominal Radiation Injury (NCT03613506) | Wuhan University | 2019-10-25 |
| Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment (NCT04143516) | Memorial Sloan Kettering Cancer Center | 2019-10-25 |
| Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer (NCT04143906) | Shandong Cancer Hospital and Institute | 2019-10-25 |
| Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients (NCT05067608) | Singapore General Hospital | 2019-10-25 |
| Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies (NCT04092673) | Effector Therapeutics | 2019-10-25 |
| Laboratory Screening of Lorcaserin for Alcohol Use Disorder (NCT04396847) | The Mind Research Network | 2019-10-25 |
| Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis (NCT04049448) | Abivax S.A. | 2019-10-25 |
| Efficacy, Safety and Re-occurrence of Pneumothorax and Hydro-pneumothorax With Talc and Pyodine Pleurodesis (NCT04130451) | Dow University of Health Sciences | 2019-10-25 |
| Erector Spinae Plane Block (NCT04118101) | Theodor Bilharz Research Institute | 2019-10-25 |
| Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia (NCT03834961) | Children's Oncology Group | 2019-10-25 |
| Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis (NCT04025554) | National Institute of Neurological Disorders and Stroke (NINDS) | 2019-10-25 |
| Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer (NCT03768570) | Canadian Cancer Trials Group | 2019-10-25 |
| A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant (NCT04006808) | GlaxoSmithKline | 2019-10-25 |
| An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU (NCT04109313) | Novartis Pharmaceuticals | 2019-10-24 |
| Bone Healing During Ninlaro Exposure (NCT04028115) | Thomas Lund | 2019-10-24 |
| Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM (NCT04052880) | Larysa Sanchez | 2019-10-24 |
| Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes. (NCT04341571) | University of Guadalajara | 2019-10-24 |
| Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) (NCT04031833) | Matinas BioPharma Nanotechnologies, Inc. | 2019-10-24 |
| Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT). (NCT03661463) | University Hospital Southampton NHS Foundation Trust | 2019-10-24 |
| Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial (NCT04104113) | National University of Singapore | 2019-10-24 |
| Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma (NCT04021420) | Assistance Publique - Hôpitaux de Paris | 2019-10-24 |
| Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels (NCT04008368) | National Heart, Lung, and Blood Institute (NHLBI) | 2019-10-24 |
| Plasmodium Immunotherapy for Advanced Malignant Solid Tumors (NCT04165590) | CAS Lamvac Biotech Co., Ltd. | 2019-10-24 |
| The Effect of Hyperoxia and Hypoxia on Fluorescence Lifetime Imaging Ophthalmoscopy in Healthy Subjects- a Randomized, Double Blind, Crossover Study (NCT04094285) | Medical University of Vienna | 2019-10-24 |
| IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase (NCT04028960) | HealthPartners Institute | 2019-10-23 |
| Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine (NCT04164758) | ACADIA Pharmaceuticals Inc. | 2019-10-23 |
| Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers (NCT04242459) | Royal Marsden NHS Foundation Trust | 2019-10-23 |
| Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa (NCT04919473) | Nanoscope Therapeutics Inc. | 2019-10-23 |
| Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma. (NCT04006262) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2019-10-23 |
| The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus (NCT04275193) | Shanghai University of Traditional Chinese Medicine | 2019-10-22 |
| Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery (NCT07515391) | Dasman Diabetes Institute | 2019-10-22 |
| Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT04047641) | M.D. Anderson Cancer Center | 2019-10-22 |
| Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN) (NCT04017455) | The Netherlands Cancer Institute | 2019-10-22 |
| Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D (NCT03920007) | Atsena Therapeutics Inc. | 2019-10-22 |
| Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (NCT04059484) | Sanofi | 2019-10-22 |
| Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients (NCT04164368) | Fudan University | 2019-10-22 |
| Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas (NCT03984448) | National Cancer Institute (NCI) | 2019-10-22 |
| SGM-101 in Locally Advanced and Recurrent Rectal Cancer (NCT04642924) | Leiden University Medical Center | 2019-10-22 |
| Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B (NCT03905655) | Romark Laboratories L.C. | 2019-10-22 |
| TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib (NCT04173585) | University Hospital Heidelberg | 2019-10-22 |
| Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD (NCT04339985) | UNION therapeutics | 2019-10-22 |
| Treatment of Central Retinal Vein Occlusion Using Stem Cells Study (NCT03981549) | The Emmes Company, LLC | 2019-10-22 |
| A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (NCT04074187) | Sanofi | 2019-10-21 |
| pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer (NCT04090528) | University of Wisconsin, Madison | 2019-10-21 |
| Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab (NCT04130516) | Linnaeus Therapeutics, Inc. | 2019-10-21 |
| Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors (NCT04041310) | Nouscom SRL | 2019-10-21 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Zampilimab in Adult Kidney Transplant Recipients With Chronic Allograft Injury (NCT04335578) | UCB Biopharma SRL | 2019-10-21 |
| A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase (NCT04126681) | Ascentage Pharma Group Inc. | 2019-10-21 |
| Norketotifen for the Treatment of Uncomplicated Influenza-like Illness (NCT04043923) | Emergo Therapeutics, Inc. | 2019-10-21 |
| Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis (NCT04132960) | UNICANCER | 2019-10-21 |
| A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects (NCT03561259) | Jubilant DraxImage Inc. | 2019-10-21 |
| Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NCT04139018) | Washington University School of Medicine | 2019-10-20 |
| Nitric Oxide During Cardiopulmonary Bypass in Neonates to Reduce Risk of Acute Kidney Injury (NCT04259684) | Children's Hospital Medical Center, Cincinnati | 2019-10-20 |
| HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial (NCT04135690) | Sun Yat-sen University | 2019-10-20 |
| Effect of Topical CBD Cream for Degenerative Hallux Disorders (NCT04103814) | Rush University Medical Center | 2019-10-20 |
| Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment (NCT04143282) | Hager salah el din | 2019-10-20 |
| A Primary Prevention Intervention for the Promotion of Psycho-social Wellbeing in Adolescent Young Carers: (NCT04114864) | Valentina Hlebec | 2019-10-20 |
| Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris (NCT03039751) | Kuopio University Hospital | 2019-10-19 |
| Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia (NCT04094090) | Goodman Eye Center | 2019-10-19 |
| Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN) (NCT04918069) | Christian Medical College, Vellore, India | 2019-10-18 |
| Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer (NCT04157491) | Sun Yat-sen University | 2019-10-18 |
| A Double-blind Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac (NCT04034290) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-10-18 |
| COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer (NCT04038489) | University of Virginia | 2019-10-18 |
| Precision Medicine With Zibotentan in Microvascular Angina (NCT04097314) | NHS Greater Glasgow and Clyde | 2019-10-18 |
| A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer (NCT04075604) | Bristol-Myers Squibb | 2019-10-18 |
| Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) (NCT03983226) | Shanghai Gynecologic Oncology Group | 2019-10-18 |
| Idelalisib+Obinutuzumab in Patients With Relapsed/Refractory Follicular Lymphoma (NCT03890289) | Fondazione Italiana Linfomi - ETS | 2019-10-18 |
| Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer (NCT04072445) | Mayo Clinic | 2019-10-18 |
| Pomalidomide for the Treatment of Bleeding in HHT (NCT03910244) | The Cleveland Clinic | 2019-10-17 |
| The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids (NCT04031131) | Julie Dawson | 2019-10-17 |
| Genetic Testing in Guiding Treatment for Patients With Brain Metastases (NCT03994796) | Alliance for Clinical Trials in Oncology | 2019-10-17 |
| Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) (NCT03822117) | Incyte Corporation | 2019-10-17 |
| Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine (NCT03714555) | HonorHealth Research Institute | 2019-10-17 |